April 18 - 19, 2016    Philadelphia PA , USA
The conference will bring together all key stakeholders, so you can collaborate and identify solutions in order to; - Maximize data quality: Enhance your trial rate of success with the perfect protocol design - Become a data company: Work with pharma’s leaders to design the analytics-driven organization of the future - Harness the right analytics: Translate and adopt the hidden message behind your data - Focus on what matters: Achieve a structured risk identification, analysis, and measurement and successfully transition to Risk Based Monitoring - Align your objectives with your sites: Collaborate with key stakeholders and optimize the information exchange Why Attend? - First clinical meeting chaired by the FDA: Hear directly from regulators on various topics such as new types patient data and when does the generated insight cross regulatory lines. - An Agenda that addresses what really matters: The unique compelling document is an objective reflection of months of research with +100 top pharma executives - Each topic will be addressed by the industry’s thought leader: Handpicked 20+ industry leading speakers including C-Suite, VP and Director level experts to share their experiences so you can design better trials using the latest technologies, analytics and techniques - Audience will make the impact in the industry: +150 pharma decision makers attending the meeting will bring back and implement exclusive insight to their organization

Venue

Location: Le Meridien Philadelphia
Contact 1421 Arch St, , PA 19102, United States Philadelphia , USA
+1 215-422-8200

Organizer

Eyeforpharma
7-9 Fashion St., 7-9 Fashion Street London E1 6PX United Kingdom
+44 (0) 207 375 7203, +44 (0) 207 375 7190

Related events